“Prospective, Single-Center, Phase II Study to Standardize the Mitotane Dosing Regimen in Combination With Platinum-Based Chemotherapy in the First-Line Treatment for Adrenocortical Cancer”. Voprosy Onkologii, vol. 72, no. 1, Mar. 2026, p. OF-2404, https://doi.org/10.37469/0507-3758-2026-72-1-OF-2404.